Last reviewed · How we verify
NCT05654727
Cognitive Functions and BDNF in T2DM and Prediabetes Patients
trial in Diabetes Type 2 in 230 participants. Completed in 1 October 2022.
1 July 2022
Quick facts
| Lead sponsor | Bezmialem Vakif University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 230 |
| Start date | 1 July 2021 |
| Primary completion | 1 July 2022 |
| Estimated completion | 1 October 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Diabetes Type 2 — all drugs for Diabetes Type 2 →
- PreDiabetes — all drugs for PreDiabetes →
- Cognitive Impairment — all drugs for Cognitive Impairment →
Sponsor
Bezmialem Vakif University
Who can join
Adults 30 to 65, any sex, with Diabetes Type 2 or PreDiabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Clinical and epidemiological studies suggest links between cognitive impairments and Type 2 diabetes (T2DM). The underlying mechanisms and causality in diabetes-related cognitive impairment are largely unknown. The aim of this study is to investigate cognitive impairment and the role of BDNF in prediabetes and diabetes patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cognition and BDNF levels in prediabetes and diabetes: A mediation analysis of a cross-sectional study.
Sumbul-Sekerci B, Sekerci A, Pasin O, Durmus E, et al · · 2023 · cited 7× · PMID 36936159 · DOI 10.3389/fendo.2023.1120127
Verify or expand the search:
- PubMed search for NCT05654727
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Type 2
Currently open trials in the same condition.
- NCT07176793 — Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes · recruiting
- NCT07485075 — Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical · NA · recruiting
- NCT07220213 — FELLAShip to Better Health · NA · recruiting
- NCT07350967 — Magnetic Compression Anastomosis Procedure for Partial Jejuno-ileal Diversion: Evaluating the Feasibility of a Novel End · NA · recruiting
- NCT07149610 — Connected Care for Type 2 Diabetes Self-Management · NA · recruiting
Other Bezmialem Vakif University trials
Trials by the same sponsor.
- NCT07369297 — PULP SENSIBILITY AND MASSETER INHIBITORY REFLEX IN DIABETIC POLYNEUROPATHY · not yet recruiting
- NCT07433595 — Association Between Child and Parental Stress and Bruxism in Children Aged 8-11 Years · not yet recruiting
- NCT07443111 — Comparison of Virtual Reality-Based and Routine Preoperative Education on Surgical Anxiety and Salivary Cortisol · NA · not yet recruiting
- NCT07421349 — Comparison of Pulmonary Functions and Respiratory Muscle Strength Between Children With Hearing Impairment and Healthy P · not yet recruiting
- NCT07414615 — Aerobic Training in Lower Extremity Lymphedema · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05654727 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bezmialem Vakif University
- Last refreshed: 19 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05654727.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing